Polson Ltd. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 137844,
    "name": "Polson",
    "stock_name": "Polson",
    "full_name": "Polson Ltd.",
    "name_url": "stocks-analysis/polson",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11,597.00",
    "chg": 342,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "11,255.00",
    "mcapval": "131.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507645,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE339F01021",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "15 ",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/polson-137844-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Polson overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-polson-overvalued-or-undervalued-3730090",
        "imagepath": "",
        "date": "2025-11-26 08:11:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Valuation Metrics and Financial Health</strong></p>\n<p>Polson’s price-to-earnings (PE) ratio stands at 27.53, which is moderate within the specialty chemicals sector. Its price-to-book value is close to 1.09, indicating the stock is trading near its book value, a sign of reasonable valuation. The enterprise value to EBITDA (EV/EBITDA) ratio is 12.11, suggesting the company is valued fairly relative to its earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>Other valuation multiples such as EV to EBIT at 21.10 and EV to sales at 1.92 further reinforce the notion that Polson is not excessively priced. The PEG ratio of 2.19, which adjusts the PE ratio for earnings growth, is somewhat elevated but still within acceptable limits for a growth-oriented specialty chemical..."
      },
      {
        "title": "Are Polson latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-polson-latest-results-good-or-bad-3729510",
        "imagepath": "",
        "date": "2025-11-25 19:12:53",
        "description": "Polson's latest financial results reflect a complex operational landscape characterized by both challenges and slight improvements in certain areas. The company reported a year-on-year increase in net sales of 1.89% for the quarter ended September 2025, contrasting with a decline of 4.90% in the same quarter of the previous year. This suggests a potential stabilization in revenue generation, although the overall growth remains modest.\n\nIn terms of profitability, Polson achieved a standalone net profit growth of 6.09% for the same quarter, compared to a decline of 6.50% in the prior year. This indicates a positive shift in net profit performance, albeit from a low base. The operating profit margin, however, saw a slight contraction, reflecting pressures on operational efficiency despite the increase in sales.\n\nThe company's full-year results for FY25 showed a decline in net sales by 3.1% year-on-year, revers..."
      },
      {
        "title": "How has been the historical performance of Polson?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-polson-3726235",
        "imagepath": "",
        "date": "2025-11-24 22:56:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance Trends</strong></p>\n<p>Over the period from fiscal year ending March 2011 to March 2015, Polson demonstrated a commendable increase in net sales, rising from ₹75.21 crores in 2011 to ₹103.91 crores in 2015. This growth reflects a compound annual increase, signalling expanding market demand or enhanced operational capacity. Other operating income, however, showed variability, peaking at ₹6.30 crores in 2012 before declining to ₹2.71 crores by 2015, indicating some fluctuations in ancillary revenue streams.</p>\n<p>Total operating income followed a similar upward trend, reaching ₹106.62 crores in 2015 from ₹76.73 crores in 2011. This growth was accompanied by rising raw material costs, which increased from ₹50.07 crores to ₹69.98 crores over the same period, re..."
      },
      {
        "title": "Polson Ltd. Q2 FY26: Stagnant Profitability and Bearish Technicals Cloud Outlook",
        "link": "https://www.marketsmojo.com/news/result-analysis/polson-ltd-q2-fy26-stagnant-profitability-and-bearish-technicals-cloud-outlook-3726185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Polson_quaterlyResult_3726185.png",
        "date": "2025-11-24 20:15:49",
        "description": "Polson Limited, the Kolhapur-based speciality chemicals manufacturer primarily engaged in producing synthetic organic tanning substances, continues to grapple with stagnant profitability and deteriorating investor sentiment. With a micro-cap market capitalisation of ₹144.00 crores, the company's shares closed at ₹11,650.00 on November 24, 2025, down 2.92% on the day, reflecting broader concerns about its financial trajectory and weak technical positioning."
      },
      {
        "title": "How has been the historical performance of Polson?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-polson-3702920",
        "imagepath": "",
        "date": "2025-11-14 23:38:23",
        "description": "Answer:\nThe historical performance of Polson shows a mixed trend in various financial metrics over the years.\n\nBreakdown:\nPolson's net sales have increased from 75.21 Cr in Mar'11 to 103.91 Cr in Mar'15, indicating a steady growth in revenue. Total operating income also rose from 76.73 Cr in Mar'11 to 106.62 Cr in Mar'15. However, the total expenditure increased significantly from 62.95 Cr in Mar'11 to 91.96 Cr in Mar'15, leading to fluctuations in operating profit, which peaked at 18.93 Cr in Mar'15 after being 13.78 Cr in Mar'11. Profit before tax showed an upward trend, reaching 9.20 Cr in Mar'15 from 6.66 Cr in Mar'14, while profit after tax increased to 6.17 Cr in Mar'15 from 4.30 Cr in Mar'14. The earnings per share (EPS) improved from 358.25 in Mar'14 to 514.17 in Mar'15, reflecting enhanced profitability. On the balance sheet, total liabilities grew from 171.55 Cr in Mar'21 to 188.70 Cr in Mar'25, w..."
      }
    ],
    "total": 88,
    "sid": "137844",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/polson-137844"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jan-2026",
      "details": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025",
      "datetime": "14-Nov-2025",
      "details": "The Board of Directors of the Company has considered and approved the standalone un-audited results for the quarter and half year ended September 30 2025 along with Statement of Assets and Liabilities Cash Flow statement and Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "14-Nov-2025",
      "details": "The Board has considered and approved the un-audited standalone results for the quarter and half year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Polson overvalued or undervalued?

2025-11-26 08:11:16

Current Valuation Metrics and Financial Health Polson’s price-to-earnings (PE) ratio stands at 27.53, which is moderate within the specialty chemicals sector. Its price-to-book value is close to 1.09, indicating the stock is trading near its book value, a sign of reasonable valuation. The enterprise value to EBITDA (EV/EBITDA) ratio is 12.11, suggesting the company is valued fairly relative to its earnings before interest, taxes, depreciation, and amortisation. Other valuation multiples such as EV to EBIT at 21.10 and EV to sales at 1.92 further reinforce the notion that Polson is not excessively priced. The PEG ratio of 2.19, which adjusts the PE ratio for earnings growth, is somewhat elevated but still within acceptable limits for a growth-oriented specialty chemical...

Are Polson latest results good or bad?

2025-11-25 19:12:53

Polson's latest financial results reflect a complex operational landscape characterized by both challenges and slight improvements in certain areas. The company reported a year-on-year increase in net sales of 1.89% for the quarter ended September 2025, contrasting with a decline of 4.90% in the same quarter of the previous year. This suggests a potential stabilization in revenue generation, although the overall growth remains modest. In terms of profitability, Polson achieved a standalone net profit growth of 6.09% for the same quarter, compared to a decline of 6.50% in the prior year. This indicates a positive shift in net profit performance, albeit from a low base. The operating profit margin, however, saw a slight contraction, reflecting pressures on operational efficiency despite the increase in sales. The company's full-year results for FY25 showed a decline in net sales by 3.1% year-on-year, revers...

How has been the historical performance of Polson?

2025-11-24 22:56:52

Revenue and Operating Performance Trends Over the period from fiscal year ending March 2011 to March 2015, Polson demonstrated a commendable increase in net sales, rising from ₹75.21 crores in 2011 to ₹103.91 crores in 2015. This growth reflects a compound annual increase, signalling expanding market demand or enhanced operational capacity. Other operating income, however, showed variability, peaking at ₹6.30 crores in 2012 before declining to ₹2.71 crores by 2015, indicating some fluctuations in ancillary revenue streams. Total operating income followed a similar upward trend, reaching ₹106.62 crores in 2015 from ₹76.73 crores in 2011. This growth was accompanied by rising raw material costs, which increased from ₹50.07 crores to ₹69.98 crores over the same period, re...

Polson Ltd. Q2 FY26: Stagnant Profitability and Bearish Technicals Cloud Outlook

2025-11-24 20:15:49

Polson Limited, the Kolhapur-based speciality chemicals manufacturer primarily engaged in producing synthetic organic tanning substances, continues to grapple with stagnant profitability and deteriorating investor sentiment. With a micro-cap market capitalisation of ₹144.00 crores, the company's shares closed at ₹11,650.00 on November 24, 2025, down 2.92% on the day, reflecting broader concerns about its financial trajectory and weak technical positioning.

How has been the historical performance of Polson?

2025-11-14 23:38:23

Answer: The historical performance of Polson shows a mixed trend in various financial metrics over the years. Breakdown: Polson's net sales have increased from 75.21 Cr in Mar'11 to 103.91 Cr in Mar'15, indicating a steady growth in revenue. Total operating income also rose from 76.73 Cr in Mar'11 to 106.62 Cr in Mar'15. However, the total expenditure increased significantly from 62.95 Cr in Mar'11 to 91.96 Cr in Mar'15, leading to fluctuations in operating profit, which peaked at 18.93 Cr in Mar'15 after being 13.78 Cr in Mar'11. Profit before tax showed an upward trend, reaching 9.20 Cr in Mar'15 from 6.66 Cr in Mar'14, while profit after tax increased to 6.17 Cr in Mar'15 from 4.30 Cr in Mar'14. The earnings per share (EPS) improved from 358.25 in Mar'14 to 514.17 in Mar'15, reflecting enhanced profitability. On the balance sheet, total liabilities grew from 171.55 Cr in Mar'21 to 188.70 Cr in Mar'25, w...

View All News